Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-02-001478
Filing Date
2002-09-03
Accepted
2002-09-03 15:08:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SNIDER d346764_13-g.txt SC 13G 19299
  Complete submission text file 0000919574-02-001478.txt   21257
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-37954 | Film No.: 02755266
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
DEERFIELD CAPITAL LP ET AL (Filed by) CIK: 0001010823 (see all company filings)